HIV Antiretroviral Drugs

Although there have been healing advancements that have helped to prolong the lives of Hiv patients, seeing life guarnatee coverage for Hiv infected individuals continues to be elusive.

According to the most recent statistics by The Henry J. Kaiser family Foundation, the whole of new Hiv infections in the U.S. Reached 56,300 in 2006. The whole of population living with Hiv/Aids was 1.1 million, with 468,000 of those individuals living with Aids. The U.S. Branch of health and Human Services reported in 2007, that the largest whole of new Hiv/Aids diagnoses for persons aged 40 to 44 accounted for 15 percent of all Hiv/Aids diagnoses in that year.

Drugs For Hiv

Respectively, the use of antiretroviral (Arv) Therapy or highly active antiretroviral therapy (Haart) such as protease inhibitors with a combination of other Hiv drugs have extended the life of those living with Hiv by slowing the progression of the disease to full-blown Aids. A study by the National Aids treatment Advocacy task in New York and the Athena National Observational Cohort Study in February 2010 found that the mean life expectancy of population living with Hiv has been extended from seven years (before 1995) to 24 years - if they effect the permissible drug therapy regimen. This includes those who take their medications on a regular basis and profess a salutary lifestyle.

Ryan Pinney, brokerage director and life impaired risk scholar at Pinney guarnatee town Inc. In Roseville, Calif. Says following the introduction of drug cocktails that counter the infection- population with Hiv can expect to live longer healthier lives.

"If you contracted Hiv in the late 70s or early 80s, it was a death sentence. Nowadays, with the expanding of antiviral drugs, it is not uncommon for population with Hiv to live 20 years without the health developing into Aids," says Pinney.
Whose at risk?

From 2004 to 2007, the numbers of Hiv/Aids diagnoses increased among men who have sex with men (Msm).

In that same timeline, the estimated numbers of Hiv/Aids diagnoses increased among male and female adults and adolescents with Hiv infection attributed to high-risk heterosexual contact.

Cumulatively, Msm (53 percent) and persons exposed to high-risk heterosexual experience (32 percent) accounted for 85 percent of all Hiv/Aids cases diagnosed in 34 states in 2007.

By gender, 77 percent of adults and adolescents living with Aids were male. Of the 104,560 female adults and adolescents living with Aids, 66 percent were exposed straight through heterosexual contact.

Source: United States Branch of health and Human Services

If you have a strong pathology at the start of the illness, meaning you have managed to keep your Cd4 T-cell count above 500 cells for at least three years, chances are you will have a greater life expectancy. In July 2008, a study conducted by the University of Bordeaux, France found that Hiv-positive males whose Cd4 count was above 500 cells for an mean of three years, had death rates that were same to those in the general population. Unfortunately, among Hiv-positive women, the death rates didn't balance out even after five years of maintaining a count above 500 cells. In fact, Hiv-positive women experienced a 2.4 percent growth in death rates when compared to the general population. More studies are pending that help justify this phenomenon.

Pinney notes that for population who covenant the disease at a young age, the improbability of receiving a life guarnatee procedure is higher. However, if you have lived longer with Hiv, it might be easier to get a policy.

"The presuppose for this is because you have a proven track record of maintaining the illness," says Pinney.

Dr. Ann Hoven, chief healing officer for the private Life Branch at the Hartford, says that insurers have carefully the possibility of outside Hiv, but there are still a whole of unknowns.

"The basic dilemma is that although the life expectancy for man with Hiv can be over 20 years, those who become newly infected are younger people," says Hoven. "The life expectancy of a man with Hiv is more like 40 to 50 years of age, and most population expect to live to be in their 60's, 70's and 80's."

She adds that it can be difficult to make assessments of a person's life expectancy with Hiv and set premiums based on the information they receive.

"The data really isn't there yet," she says. "There are population who seem to be unyielding to infection where their immune system takes care of it, and then there are others that are thoroughly vulnerable to this illness. The results of the studies that have been conducted haven't provided any definitive data to pull from when it comes to estimating how long an private can live with this illness. It's very case by case."

Limited options

When it comes to purchasing life insurance, most population who have been diagnosed with Hiv will be faced with an automatic decline or enormously high premiums.

"You would have to have a breakthrough to make the numbers work out when trying to write a procedure for man with Hiv," says Hoven. "When you look at the numbers the cost would be so astonomical that no one would buy it [the policy]."

"If you have been diagnosed with Hiv, getting life guarnatee may be tough, but it's not unheard of," says Pinney. "It can be fulfilled, if you receive guarnatee straight through a group plan, such as an employer, trade relationship or union."

However, if you are Hiv-positive and you attempt to get life guarnatee on your own, most guarnatee clubs will refuse to sell you a policy, this includes clubs that offer "simplified issue" life guarnatee coverage where you would only have to retort a few health questions. Even when applying for a simplified issue policy, you will likely be required to retort questions about Hiv/Aids. Other, more original private life insurers may also ask that you take an Hiv test.

"The requirement by insurers of an Hiv test varies by state and the face value of the policy," says Kim McKeown, spokesperson for the society of Actuaries. "Nonetheless, the underwriting process is used to remarked information on one's healing profile, and if the man is taking antiviral drugs which would be found in the healing record, this might prompt an insurer to ask for an Hiv test. Even with the best medication, folks with Hiv do have a shortened life expectancy so the best information potential is essential during the underwriting process."

Mckeown adds that from an guarnatee company's perspective, request a potential policyholder to take an Hiv test is really no distinct than request man about his or her family health history, what types of prescriptions they take daily, or if they smoke.

If you are able to get a simplified issue guarnatee plan, they have a little face value amount, typically 0,000 to 0,000 on the high-end of the spectrum.

A more viable option is purchasing a "guaranteed issue" life guarnatee plan. When a procedure is carefully "guaranteed issue" this is the maximum whole of coverage allowed to an private without a healing evaluation. Anything can buy a guaranteed issue plan since they do not need a healing exam, but they are ordinarily nuts and bolts policies that only contribute a death benefit. The death advantage is commonly ,000 or less and if you die within the first two years after you buy the policy, your loved ones could receive nothing.

There are also small group plans to reconsider that are essentially employer-sponsored specialty plans that cover key employees at a company.

Pinney recalls a situation where a group of partners at a firm requested a guaranteed issue group plan that would cover all the senior and junior partners at the firm. One of the individuals was Hiv-positive and the group managed to negotiate a procedure that provided over a million dollars in life guarnatee to each man in the group.

While it's clear that this method can work, Pinney says that because of the stigma attached to population living with Hiv, this is primarily the presuppose why most employees won't propose this type of coverage to their employer.

While man with Hiv may be able to get a life guarnatee procedure from an guarnatee firm that specializes in high-risk cases, it's confident that it will most likely be a high-priced procedure with a graded benefit. For example, a 40-year-old Hiv-positive male can get a ,000 whole life policy, but he would pay a high annual prime of ,600.

"There are very few companies, maybe three or four that offer policies for population with Hiv," explains Pinney. "What they whole to is a guaranteed issue whole life procedure with a graded death advantage or a advantage that increases slowly with age and at last levels off during the life of the policy."

Still, Pinney says that if you die during the first, second or third year of the procedure you may only receive your premiums and dividends with interest, other clubs may only payout a specified percentage of the advantage whole if you die within that timeframe.

Will insurers cover Hiv in the future?

Guaranteed Trust Life guarnatee Co. Based in Glenview, Ill., was the first guarnatee firm to offer "impaired risk" whole life guarnatee to Hiv-positive individuals. The firm ceased selling the policies in 2004.

"One of the biggest problems with pricing an Hiv procedure is figuring out how to price it without getting beat up," recalls Pinney. "At the start of contribution such a product policyholders were seeing at a flat extra of per ,000 in insurance."

Pinney said that recently he attended a life guarnatee argument and posed the possibility of an Hiv life procedure to major life insurers. Unlike Hiv, other healing conditions, such as cancer or heart disease have a longer track record of population having these conditions and best statistical data that an insurer can draw from. Even though Hiv/Aids has been colse to since the early eighties, Pinney notes that the underwriting science hasn't caught up with healing science yet.

"I don't see this type of product entering the market again anytime soon," notes Pinney. "Part of the qoute is there is no mortality data ready to generate an correct pricing model. I would be surprised if any guarnatee firm would even remotely reconsider it for quite awhile."

"When we solve the societal issues concering Hiv and find best ways to treat the illness or even a vaccine, I think that will be when the situation changes," says Hoven. "I really don't see this happening in the next five years, but we're definitely getting closer to it. "

Hoven recommends that if you have been diagnosed with Hiv and your owner offers life insurance, it's best to take advantage of it.

"You wouldn't go straight through healing underwriting and you would receive the group-based prime that includes population who have a range of distinct healing concerns," says Hoven. "Also, if you retire, most group plans allow the procedure to be converted to a whole life policy."

Friends Link : hiv antiretroviral drugs